Purpose-Built Facilities for Cell and Gene Therapies


Advanced Early Phase Development Solutions

Altasciences has a purpose-built facility focused on exploratory and early development research in nonhuman primates (NHPs). Our Sacramento (CA) site, in particular, is dedicated to developing cell and gene therapies, such as adeno-associated virus (AAV) or lentivirus (lenti) products, and applying gene editing technologies like CRISPR/cas9.

Discover the Altasciences difference:

•    Extensive in-house capabilities and experience (including historical background data)
•    Operational experience with infant/juvenile NHPs for long-term studies
•    Surgery expertise for biopsies, such as in gene editing studies requiring repeated liver sampling
•    Special necropsy procedures to avoid contamination and ensure the integrity of genomic material in tissues
•    GLP laboratory in Seattle (WA) to perform qPCR/RT-qPCR of vector and biodistribution and persistence of vector/transgene in tissues

Consult with one of our experts to discuss your study needs.

Related resources that may interest you:

•    Webpage: Full Range of Preclinical Drug Development Solutions
•    Fact Sheet: Preclinical Services Capabilities
•    The Altascientist: Planning Your Preclinical Assessment

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.